{
    "title": "Sarepta Duchenne gene therapy heads to FDA advisory meeting",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12076697/Sarepta-Duchenne-gene-therapy-heads-FDA-advisory-meeting.html",
    "date": "2023-05-12",
    "keywords": [
        "gene",
        "therapy",
        "trial",
        "fda",
        "dmd",
        "leo",
        "agency",
        "treatment",
        "disease",
        "approval",
        "food",
        "drug",
        "administration",
        "duchenne",
        "dystrophy",
        "meeting",
        "friday",
        "onetime",
        "disorder",
        "doorstep",
        "way",
        "organization",
        "muscle",
        "failure",
        "subset",
        "longterm",
        "weight",
        "gain",
        "osteoporosis",
        "midstage",
        "version",
        "dystrophin",
        "protein",
        "patient",
        "ability",
        "data",
        "staff",
        "wednesday",
        "evidence",
        "sarepta",
        "latestage",
        "september",
        "therapys",
        "market",
        "surrogate",
        "likelihood",
        "benefit",
        "versus",
        "function",
        "survival",
        "peter",
        "march",
        "use",
        "efficacy",
        "chance",
        "analyst",
        "joseph",
        "schwartz",
        "backdrop",
        "panel",
        "advise",
        "decision",
        "end",
        "month",
        "reporting",
        "bengaluru",
        "editing",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}